Diagnosis
The three numbers that matter
Six or more of nine symptoms (from the inattentive category, the hyperactive-impulsive category, or both) for children, five or more for adults age 17 and older. Symptoms must have been present before age 12, persist for at least 6 months, and appear in two or more settings (like both home and school), not just one. The symptoms must clearly interfere with functioning, not just be mildly annoying.
Three presentations: Combined (meets both inattentive and hyperactive-impulsive thresholds), Predominantly Inattentive, and Predominantly Hyperactive-Impulsive.
💡 Memory Trick — Why "Two Settings" Matters So Much
A child who's only difficult at home, or only struggles at school, doesn't meet criteria, however real the problem feels in that one setting. ADHD symptoms have to show up across multiple contexts, because a child who's fine at school but has behavioral issues only at home more likely reflects something situational, not a pervasive neurodevelopmental pattern. This is exactly why teacher input/reports are typically part of a real ADHD evaluation, not just a parent's account.
Stimulant Medications
Methylphenidate and amphetamine-based medications
The paradoxical calming effect
Stimulants increase dopamine and norepinephrine activity, particularly in the prefrontal cortex, the brain region responsible for attention and impulse control. In a brain with ADHD, this improves focus and reduces impulsivity, rather than causing the expected stimulant "speeding up" effect, which is why these medications work as prescribed rather than worsening hyperactivity.
Cardiac screening comes first
Before starting any stimulant, screen for structural cardiac abnormalities, cardiomyopathy, or serious arrhythmias, since stimulants have been associated with rare but serious cardiovascular events, including sudden death, in patients with underlying heart problems. Blood pressure and heart rate are monitored throughout treatment.
💊 A family history of sudden cardiac death or an unevaluated heart murmur are red flags to raise before starting stimulant therapy, not after.
Growth monitoring in children
Stimulants can suppress appetite and slow growth rate in pediatric patients. Height and weight should be tracked regularly on a growth chart, and a plateau or drop-off is worth discussing with the provider rather than dismissing as normal variation.
Timing and administration
Given in the morning (or at breakfast/lunch) to minimize insomnia. Extended-release formulations should never be crushed, chewed, or divided. These are controlled substances with real abuse potential, and are contraindicated with MAOIs or within 14 days of MAOI use.
🏥 ADHD Scenarios — Apply What You've Learned
Three scenarios. Identify the correct interpretation or action.
1
Scenario: A 7-year-old is reported by parents as extremely hyperactive at home, but the teacher reports no concerns at school.
Correct interpretation: This does not meet the "two or more settings" criterion for ADHD. The behavior pattern being confined to one setting suggests a different explanation is more likely.
2
Scenario: A child newly started on methylphenidate has a parent who mentions a family history of sudden cardiac death in a young relative.
Correct action: This should have been screened for before starting the stimulant. Notify the provider, cardiac evaluation may be warranted given this history.
3
Scenario: A child on long-term stimulant therapy shows a flattening growth curve at their well-child visit.
Correct action: This is a known stimulant side effect. Discuss with the provider, options may include a medication holiday, dose adjustment, or closer nutritional monitoring.
📌 NCLEX Application
NCLEX tests the diagnostic criteria and stimulant medication safety heavily.
Rules to know cold:
• 6 of 9 symptoms (children) or 5 of 9 (adults 17+), before age 12, in 2+ settings
• Cardiac screening before starting stimulants; ongoing BP/HR monitoring
• Growth (height/weight) should be tracked regularly in children on stimulants
• Stimulants are given in the morning to minimize insomnia
• Contraindicated with MAOIs or within 14 days of MAOI use
• Extended-release formulations are never crushed, chewed, or divided
Common NCLEX trap: a question describes a hyperactive child at home only, with no reported concerns at school, and expects the student to recognize this doesn't meet the "two settings" diagnostic requirement.
⚠️ The Trap — Assuming Stimulants Will Make an ADHD Patient More Hyperactive
It seems logical that giving a "stimulant" to an already hyperactive child would make things worse. This intuitive but incorrect reasoning can lead to real hesitation or confusion about the medication's purpose.
In ADHD specifically, stimulants improve prefrontal cortex function, the brain region governing attention and impulse control, producing a calming, focusing effect rather than increased hyperactivity. This is the paradoxical effect that makes stimulant therapy the first-line pharmacologic treatment for ADHD.
NCLEX angle: "A parent asks why a stimulant medication is being prescribed for their hyperactive child. What is the nurse's best response?" → Explain that in ADHD, stimulants improve attention and impulse control by enhancing prefrontal cortex activity, rather than increasing hyperactivity.
✓ Quick Self-Test
Answer before checking:
1. How many symptoms are required for an ADHD diagnosis in children vs. adults, and from what timeframe?
2. Why does "two or more settings" matter for diagnosis?
3. Why do stimulants have a calming effect in ADHD rather than worsening hyperactivity?
4. What must be screened before starting stimulant medication?
5. Why is growth monitored regularly in children on stimulant therapy?
Answers:
1. 6 of 9 symptoms for children, 5 of 9 for adults 17+, with onset before age 12 and symptoms persisting at least 6 months.
2. It distinguishes a pervasive neurodevelopmental pattern from situational behavior confined to just one environment.
3. Stimulants increase dopamine/norepinephrine activity in the prefrontal cortex, improving attention and impulse control rather than causing generalized stimulation.
4. Cardiac history — structural abnormalities, cardiomyopathy, or serious arrhythmias, due to rare but serious cardiovascular event risk.
5. Stimulants can suppress appetite and slow growth rate in pediatric patients; tracking height/weight catches this early.
→